These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 9434479

  • 1. [Continuous subcutaneous insulin infusion].
    Ito H, Kanatsuka A.
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N, Shalitin S, Phillip M.
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N, Shashaj B.
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [Abstract] [Full Text] [Related]

  • 7. [Hypoglycemia in patients treated with an external insulin pump].
    Laurent JC, Waeber G, Ruiz J, Carron PN.
    Rev Med Suisse; 2011 Jan 19; 7(278):166-9. PubMed ID: 21400952
    [Abstract] [Full Text] [Related]

  • 8. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C.
    Acta Diabetol; 2010 Dec 19; 47(4):325-30. PubMed ID: 20842389
    [Abstract] [Full Text] [Related]

  • 9. Prime-time hypoglycemia: factitious hypoglycemia during insulin-pump therapy.
    Osipoff JN, Sattar N, Garcia M, Wilson TA.
    Pediatrics; 2010 May 19; 125(5):e1246-8. PubMed ID: 20385648
    [Abstract] [Full Text] [Related]

  • 10. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D, Moberg E, Palmér M.
    Lakartidningen; 2010 May 19; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract] [Full Text] [Related]

  • 11. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA, Jørgensen UL, Gjessing HJ.
    J Diabetes Sci Technol; 2017 May 19; 11(3):631-632. PubMed ID: 27595713
    [No Abstract] [Full Text] [Related]

  • 12. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC.
    Diabetes Technol Ther; 2011 Jul 19; 13(7):695-8. PubMed ID: 21668344
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A, Jeitler K, Berghold A, Horvath K, Pieber TR.
    Diabet Med; 2009 Mar 19; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract] [Full Text] [Related]

  • 15. Factitious self-manipulation of the external insulin pump in adolescents with Type 1 diabetes.
    Moreau F, Spizzo H, Bursztejn C, Berthoux V, Agin A, Pinget M, Pasquali JL, Kessler L.
    Diabet Med; 2011 May 19; 28(5):623-4. PubMed ID: 21303404
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight.
    Pryce R.
    BMJ; 2009 Jan 05; 338():a2218. PubMed ID: 19124546
    [No Abstract] [Full Text] [Related]

  • 18. Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy.
    Viñals C, Pané A, Quirós C, Giménez M, Conget I.
    Diabetes Technol Ther; 2017 Aug 05; 19(8):491-492. PubMed ID: 28594566
    [No Abstract] [Full Text] [Related]

  • 19. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K, Alahdab F, Tamhane SU, McCoy RG, Prokop LJ, Murad MH.
    Endocrine; 2017 Jan 05; 55(1):77-84. PubMed ID: 27477293
    [Abstract] [Full Text] [Related]

  • 20. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ, Cohen H, Chu V.
    J Clin Pharmacol; 2007 Jul 05; 47(7):890-903. PubMed ID: 17585117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.